A medical worker fills a syringe with Sputnik V (Gam-COVID-Vac) vaccine before administering an injection during the vaccination against the coronavirus disease (COVID-19) at a clinic in the town of Domodedovo near Moscow, Russia December 3, 2020. REUTERS/Maxim Shemetov
MOSCOW (Reuters) - Muscovites from high-risk groups such as healthcare workers began registering for jabs of a Russian-made COVID-19 vaccine on Friday, two days after President Vladimir Putin called for large-scale vaccinations.
Sputnik V, one of two Russian-made vaccines to have received regulatory approval in Russia despite clinical trials being incomplete, requires two injections. Interim trials showed it is 92% effective at protecting people from COVID-19.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
